Lindsey Hickson, AUD | |
117 E Kentucky St, Louisville, KY 40203-2793 | |
(502) 371-9910 | |
(502) 515-3325 |
Full Name | Lindsey Hickson |
---|---|
Gender | Female |
Speciality | Qualified Audiologist |
Experience | 3 Years |
Location | 117 E Kentucky St, Louisville, Kentucky |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790351120 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | 270068 (Kentucky) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Edith And Henry Heuser Hearing Institute | 2062451610 | 10 |
News Archive
Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive acquisition and license agreement with Handa Pharmaceuticals, LLC to acquire Handa's Abbreviated New Drug Application (ANDA) for quetiapine fumarate extended-release tablets, the generic version of AstraZeneca's Seroquel XR.
"It is not just quantity of aid that counts nowadays, but the quality and perspective of that aid, as well as innovation, investment and experience domestically," Jonathan Glennie, a research fellow at the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog."
While many college athletes may seem like they are in peak physical condition, they can still face significant cardiovascular risks.
Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the second quarter ended June 30, 2012.
› Verified 9 days ago
Provider Name | Edith & Henry Heuser Hearing Institute |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1881668663 PECOS PAC ID: 2062451610 Enrollment ID: O20050503000470 |
News Archive
Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive acquisition and license agreement with Handa Pharmaceuticals, LLC to acquire Handa's Abbreviated New Drug Application (ANDA) for quetiapine fumarate extended-release tablets, the generic version of AstraZeneca's Seroquel XR.
"It is not just quantity of aid that counts nowadays, but the quality and perspective of that aid, as well as innovation, investment and experience domestically," Jonathan Glennie, a research fellow at the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog."
While many college athletes may seem like they are in peak physical condition, they can still face significant cardiovascular risks.
Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the second quarter ended June 30, 2012.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Lindsey Hickson, AUD 117 E Kentucky St, Louisville, KY 40203-2793 Ph: (502) 371-9910 | Lindsey Hickson, AUD 117 E Kentucky St, Louisville, KY 40203-2793 Ph: (502) 371-9910 |
News Archive
Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive acquisition and license agreement with Handa Pharmaceuticals, LLC to acquire Handa's Abbreviated New Drug Application (ANDA) for quetiapine fumarate extended-release tablets, the generic version of AstraZeneca's Seroquel XR.
"It is not just quantity of aid that counts nowadays, but the quality and perspective of that aid, as well as innovation, investment and experience domestically," Jonathan Glennie, a research fellow at the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog."
While many college athletes may seem like they are in peak physical condition, they can still face significant cardiovascular risks.
Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the second quarter ended June 30, 2012.
› Verified 9 days ago
Fawn E. Wujick, M.S. Audiologist Medicare: Medicare Enrolled Practice Location: 13403 Forest Springs Dr, Louisville, KY 40245 Phone: 502-693-1449 Fax: 188-851-1026 | |
Special Care Hearing Of Kentucky Llc Audiologist Medicare: Medicare Enrolled Practice Location: 12910 Shelbyville Rd, Louisville, KY 40243 Phone: 855-259-9183 Fax: 502-254-4069 | |
Mark Jeffrey Hales, MA CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4004 Dupont Cir, Ste 220, Louisville, KY 40207 Phone: 502-893-0159 | |
Brittany Ann Brose, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 401 E Chestnut St, Suite 710, Louisville, KY 40202 Phone: 502-583-8303 | |
Mr. Eric Scott Cahill, MS CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 982 Eastern Pkwy, Building B, Louisville, KY 40217 Phone: 502-595-4459 | |
Special Care Hearing Of Indiana Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 12910 Shelbyville Rd, Louisville, KY 40243 Phone: 855-259-9183 Fax: 502-254-4086 | |
Deanna S Brown, MS Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2944 Breckenridge Ln, Louisville, KY 40220 Phone: 502-893-0159 Fax: 502-213-3892 |